Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval entities : Ani pharmaceuticals, inc. save search
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
Published: 2024-01-16 (Crawled : 12:00) - globenewswire.com
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.29%
fda approval pharmaceuticals
ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: -1.37%
cortrophin fda approval treatment pharmaceuticals commercial
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
Published: 2023-09-12 (Crawled : 11:00) - globenewswire.com
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 1.27%
H: 1.03%
C: -1.62%
fda approval pharmaceuticals
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
Published: 2023-08-28 (Crawled : 11:00) - globenewswire.com
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 1.24%
H: 0.92%
C: -2.35%
fda approval pharmaceuticals
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
Published: 2023-05-15 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.6%
H: 3.23%
C: -2.48%
fda approval pharmaceuticals commercialization
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP
Published: 2023-04-24 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 2.56%
H: 0.34%
C: -4.49%
fda approval pharmaceuticals
ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP
Published: 2023-04-04 (Crawled : 18:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.98%
H: 0.15%
C: -3.78%
fda approval pharmaceuticals
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
Published: 2022-11-28 (Crawled : 12:20) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: -0.48%
H: 0.1%
C: -3.5%
fda pharmaceuticals solution approval
ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
Published: 2022-11-16 (Crawled : 13:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 2.16%
H: 2.72%
C: 1.26%
fda pharmaceuticals approval
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP
Published: 2022-08-16 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 5.68%
H: 0.0%
C: -4.95%
fda approval
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 6.12%
H: 1.73%
C: -0.88%
fda approval
ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.4%
H: 1.48%
C: 0.49%
fda approval
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
Published: 2021-12-21 (Crawled : 12:30) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 1.79%
H: 0.38%
C: 0.33%
fda als fda approval approval
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
Published: 2021-11-01 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 9.77%
H: 41.84%
C: 31.63%
multiple sclerosis fda rheumatoid arthritis fda approval sclerosis approval syndros
Competitive Generic Therapy Approvals
Published: 2021-03-31 (Crawled : 16:34) - fda.gov
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.61%
H: 9.81%
C: 9.05%
therapy approval
Competitive Generic Therapy Approvals
Published: 2021-03-15 (Crawled : 00:00) - fda.gov
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.12%
H: 2.78%
C: 1.95%
therapy approval
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 0.88%
H: 2.16%
C: 1.42%
approval
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
CZOO | $9.98 100.0% 330K
|
AMST | $3.48 74.0% 21M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.2184 43.4% 36M
|
Consumer Services
MULN | News | $3.445 26.19% 980K
|
Information
LICN | $0.6987 24.77% 4.4M
|
HKIT | $1.6 20.3% 160K
|
Technology Services
IMMP | $2.95 17.53% 260K
|
Health Technology
MTC | $2.63 17.41% 3.3M
|
Technology Services
ACB | $7.32 16.56% 780K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.